about
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debateSingle-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and ResearchNK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Cancer stem cells (CSCs), cervical CSCs and targeted therapiesCould Vitamin D Analogues Be Used to Target Leukemia Stem Cells?Improving the clinical impact of biomaterials in cancer immunotherapy.The Reverse Transcriptase Encoded by LINE-1 Retrotransposons in the Genesis, Progression, and Therapy of CancerCancer Metabolism: A Modeling PerspectiveTumor resistance to vascular disrupting agents: mechanisms, imaging, and solutionsSingle-cell analysis tools for drug discovery and developmentTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsDifferentiation and transdifferentiation potentials of cancer stem cellsTwenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?Intra-tumor heterogeneity of cancer cells and its implications for cancer treatmentCell injury, retrodifferentiation and the cancer treatment paradoxGetting Down to Specifics: Profiling Gene Expression and Protein-DNA Interactions in a Cell Type-Specific MannerPrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerRecapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture ModelsArgonaute 2: A Novel Rising Star in Cancer ResearchStem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic LeukemiaInduced pluripotent stem cell technology for dissecting the cancer epigenomeCancer stem cells--important players in tumor therapy resistanceThe cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistanceGlioblastoma cancer stem cells: Biomarker and therapeutic advancesTumour heterogeneity and the evolution of polyclonal drug resistanceIntratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasisAnti-cancer vaccines - a one-hit wonder?Modulation of the tumor microenvironment for cancer treatment: a biomaterials approachIntegrative analysis of cancer imaging readouts by networksBreast cancer intra-tumor heterogeneityCancer evolution: mathematical models and computational inferenceHeterogeneity of epidermal growth factor receptor signalling networks in glioblastomaTumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectivesAn updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versaProteolytic and non-proteolytic regulation of collective cell invasion: tuning by ECM density and organization.An Emerging Allee Effect Is Critical for Tumor Initiation and PersistenceEstimating dose painting effects in radiotherapy: a mathematical modelTools for Single-Cell Kinetic Analysis of Virus-Host InteractionsKRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy
P2860
Q24273274-350BEE93-8C35-4177-BEB2-43BF941CB5F3Q26744582-D55912F8-8CA4-4358-AFCD-01600EEA9BE7Q26746478-9B234863-F2C9-4D84-B731-5DB73BF837BDQ26747144-6B408F5F-54F7-4577-ADAA-A3ED2BB50D92Q26747513-F2B8ACDF-3C6D-4872-AD8C-7E4ED06AC1C6Q26766267-C6340C71-0A76-454C-822D-321E5652674CQ26767214-83851BF6-3C6A-452E-B466-3C46CF83F457Q26770819-00DAFB19-32BE-4B81-AC76-68F9F6DEDCABQ26774355-A454B407-D8A1-4B21-8A44-7166CC55AE5CQ26775754-912ED58F-470F-4C44-88A0-2223D507F39DQ26776394-415143B6-8BE5-49A4-84F9-119C04613F23Q26782242-199C914D-21DB-4CF3-A83C-9B7152312756Q26782649-ACA015AB-84F4-4904-BEC2-B6F6915E404AQ26783055-D68D3104-37A1-45F4-A00E-6383149ACE58Q26783201-BD3E4419-6E7E-4BE7-B731-443CCCF60DF5Q26786615-3037E7D4-4B08-4C75-BF38-1F6B8D7E4DCAQ26795466-CB252DC9-F7C8-452E-BD20-D5ECCF26142EQ26797285-31F85F5B-772A-4316-BB3A-09C31562EC9EQ26797294-42B59144-2074-4D71-921E-B0635D8E07DEQ26799954-687015E9-0AA2-4DD8-8CEF-D379BF97540EQ26801711-B5020C5C-CB07-4C0F-A285-CD4565B1FA15Q26823015-07575027-6104-4F8F-84AE-13D8CEB4A1E1Q26824147-7098F40D-CEEC-409C-B42A-A319335AEC80Q26829987-32ADB8E0-17E8-4800-9B0C-9CD60F519021Q26859782-75FFC0E2-D7F0-4516-85C7-8FF21341B6D9Q26866803-C31E7946-8242-4B10-85B4-86DAB57109EEQ26991480-E2C8D452-2510-4448-9C64-37E31608E40EQ26995164-5F9A5DB0-FC2D-44BA-81FE-5ED0F133CBB8Q26996790-64030FA5-3EB1-49D8-8A4B-8F525A31CB40Q26999069-6D829958-FCD0-4A71-B4E4-6FA046448C25Q27000086-0FE57686-718E-409F-8592-BA224709234FQ27002537-9102E14A-9E60-4909-8AC6-3F698DA9E18AQ27013006-66590950-3F29-40CA-A3F8-004EF519EC08Q27014117-68BE4FDE-F3F6-4F5B-B0FD-31908D55A5DFQ27027592-C803920F-29DB-479A-8EE8-0AAFA7B69A39Q27300808-78F94655-0E1A-42C7-9ACA-E432F545B0D6Q27318402-65802014-3BF9-4BB0-A183-FD7C8B3B2252Q27321048-1CD42034-4EF5-4FF2-BCD0-D9D61838656EQ27334856-7CF99824-F9D7-4A46-9724-6749870FE8D9Q28069764-20E3BE1B-FA1B-4B69-A0D0-02DC2FAE4A99
P2860
description
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Nature
@fr
artículu científicu espublizáu en 2013
@ast
scientific article (publication date: 19 September 2013)
@en
wetenschappelijk artikel (gepubliceerd op 2013/09/19)
@nl
наукова стаття, опублікована у вересні 2013
@uk
مقالة علمية (نشرت في 19-9-2013)
@ar
name
Tumour heterogeneity and cancer cell plasticity
@ast
Tumour heterogeneity and cancer cell plasticity
@en
type
label
Tumour heterogeneity and cancer cell plasticity
@ast
Tumour heterogeneity and cancer cell plasticity
@en
prefLabel
Tumour heterogeneity and cancer cell plasticity
@ast
Tumour heterogeneity and cancer cell plasticity
@en
P2860
P3181
P356
P1433
P1476
Tumour heterogeneity and cancer cell plasticity
@en
P2093
Corbin E Meacham
P2860
P2888
P304
P3181
P356
10.1038/NATURE12624
P407
P577
2013-09-19T00:00:00Z
P6179
1014627596